4.8 Article

BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers

期刊

NUCLEIC ACIDS RESEARCH
卷 43, 期 3, 页码 -

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gku1211

关键词

-

资金

  1. Dana-Farber Cancer Institute
  2. Brigham and Women's Hospital

向作者/读者索取更多资源

Genomic structural variation (SV), a common hallmark of cancer, has important predictive and therapeutic implications. However, accurately detecting SV using high-throughput sequencing data remains challenging, especially for 'targeted' resequencing efforts. This is critically important in the clinical setting where targeted resequencing is frequently being applied to rapidly assess clinically actionable mutations in tumor biopsies in a cost-effective manner. We present BreaKmer, a novel approach that uses a 'kmer' strategy to assemble misaligned sequence reads for predicting insertions, deletions, inversions, tandem duplications and translocations at base-pair resolution in targeted resequencing data. Variants are predicted by realigning an assembled consensus sequence created from sequence reads that were abnormally aligned to the reference genome. Using targeted resequencing data from tumor specimens with orthogonally validated SV, non-tumor samples and whole-genome sequencing data, BreaKmer had a 97.4% overall sensitivity for known events and predicted 17 positively validated, novel variants. Relative to four publically available algorithms, BreaKmer detected SV with increased sensitivity and limited calls in non-tumor samples, key features for variant analysis of tumor specimens in both the clinical and research settings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Genomic basis for RNA alterations in cancer

Claudia Calabrese, Natalie R. Davidson, Deniz Demircioglu, Nuno A. Fonseca, Yao He, Andre Kahles, Kjong-Van Lehmann, Fenglin Liu, Yuichi Shiraishi, Cameron M. Soulette, Lara Urban, Liliana Greger, Siliang Li, Dongbing Liu, Marc D. Perry, Qian Xiang, Fan Zhang, Junjun Zhang, Peter Bailey, Serap Erkek, Katherine A. Hoadley, Yong Hou, Matthew R. Huska, Helena Kilpinen, Jan O. Korbel, Maximillian G. Marin, Julia Markowski, Tannistha Nandi, Qiang Pan-Hammarstrom, Chandra Sekhar Pedamallu, Reiner Siebert, Stefan G. Stark, Hong Su, Patrick Tan, Sebastian M. Waszak, Christina Yung, Shida Zhu, Philip Awadalla, Chad J. Creighton, Matthew Meyerson, B. F. Francis Ouellette, Kui Wu, Huanming Yang, Alvis Brazma, Angela N. Brooks, Jonathan Goke, Gunnar Raetsch, Roland F. Schwarz, Oliver Stegle, Zemin Zhang

NATURE (2020)

Article Oncology

Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors

Zhouwei Zhang, Netta Makinen, Yosuke Kasai, Grace E. Kim, Begona Diosdado, Eric Nakakura, Matthew Meyerson

GENES CHROMOSOMES & CANCER (2020)

Article Multidisciplinary Sciences

Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer

Li C. Xia, Paul Van Hummelen, Matthew Kubit, HoJoon Lee, John M. Bell, Susan M. Grimes, Christina Wood-Bouwens, Stephanie U. Greer, Tyler Barker, Derrick S. Haslem, James M. Ford, Gail Fulde, Hanlee P. Ji, Lincoln D. Nadauld

SCIENTIFIC REPORTS (2020)

Article Oncology

Genomic Profiling of Prostate Cancers from Men with African and European Ancestry

Yusuke Koga, Hanbing Song, Zachary R. Chalmers, Justin Newberg, Eejung Kim, Jian Carrot-Zhang, Daphnee Piou, Paz Polak, Sarki A. Abdulkadir, Elad Ziv, Matthew Meyerson, Garrett M. Frampton, Joshua D. Campbell, Franklin W. Huang

CLINICAL CANCER RESEARCH (2020)

Editorial Material Biochemistry & Molecular Biology

Bacterial invaders drive CRC progression

Matthew Meyerson

SCIENCE SIGNALING (2020)

Article Biochemical Research Methods

Quantification of aneuploidy in targeted sequencing data using ASCETS

Liam F. Spurr, Mehdi Touat, Alison M. Taylor, Adrian M. Dubuc, Juliann Shih, David M. Meredith, William Pisano, Matthew L. Meyerson, Keith L. Ligon, Andrew D. Cherniack, Yvonne Y. Li, Rameen Beroukhim

Summary: The expansion of targeted panel sequencing efforts has created opportunities for large-scale genomic analysis, but tools for copy-number quantification on panel data are lacking. We introduce ASCETS, a method for the efficient quantitation of arm and chromosome-level copy-number changes from targeted sequencing data.

BIOINFORMATICS (2021)

Article Oncology

Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions

Harshabad Singh, Yvonne Y. Li, Liam F. Spurr, Atul B. Shinagare, Ritika Abhyankar, Emma Reilly, Lauren K. Brais, Anwesha Nag, Matthew D. Ducar, Aaron R. Thorner, Geoffrey Shapiro, Rachel B. Keller, Cheta Siletti, Jeffrey W. Clark, Anna F. Farago, Jessica J. Lin, George D. Demetri, Rahul Gujrathi, Matthew H. Kulke, Laura E. MacConaill, Azra H. Ligon, Ewa Sicinska, Matthew L. Meyerson, Jeffrey A. Meyerhardt, Andrew D. Cherniack, Brian M. Wolpin, Kimmie Ng, Marios Giannakis, Jason L. Hornick, James M. Cleary

Summary: RTK fusions in colorectal cancer are rare but enrich in right-sided and MMR-D colorectal cancers. They occur in RAS and BRAF wild-type tumors, providing an important therapeutic target for MSS colorectal cancer.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations

Jian Carrot-Zhang, Giovanny Soca-Chafre, Nick Patterson, Aaron R. Thorner, Anwesha Nag, Jacqueline Watson, Giulio Genovese, July Rodriguez, Maya K. Gelbard, Luis Corrales-Rodriguez, Yoichiro Mitsuishi, Gavin Ha, Joshua D. Campbell, Geoffrey R. Oxnard, Oscar Arrieta, Andres F. Cardona, Alexander Gusev, Matthew Meyerson

Summary: This study found significant associations between Native American ancestry and somatic genomic landscape in lung cancer patients, suggesting that germline genetics may play a key role in tumor mutation burden and specific driver mutations. Further studies are needed to identify the genetic alleles underlying the variation in EGFR and KRAS mutation frequencies.

CANCER DISCOVERY (2021)

Article Immunology

Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells

Mark N. Lee, Matthew Meyerson

Summary: This study introduces a high-throughput epitope identification system that combines T cell-secreted cytokines capture, cell sorting, and next-generation sequencing to identify new class I- and class II-restricted epitopes. The technology successfully validated known viral, neoepitope, and autoimmune epitope-specific TCR targets, as well as discovered new epitopes encoded by the human cytomegalovirus genome. This cytokine capture-based assay enables pooled screening of thousands of encoded peptides for epitope discovery and may lead to identification of HLA-epitope-TCR complexes relevant to disease control, etiology, or treatment.

SCIENCE IMMUNOLOGY (2021)

Correction Cell Biology

Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway (vol 34, 108707-1.e1, 2021)

Jian Carrot-Zhang, Xiaotong Yao, Siddhartha Devarakonda, Aditya Deshpande, Jeffrey S. Damrauer, Tiago Chedraoui Silva, Christopher K. Wong, Hyo Young Choi, Ina Felau, A. Gordon Robertson, Mauro A. A. Castro, Lisui Bao, Esther Rheinbay, Eric Minwei Liu, Tuan Trieu, David Haan, Christina Yau, Toshinori Hinoue, Yuexin Liu, Ofer Shapira, Kiran Kumar, Karen L. Mungall, Hailei Zhang, Jake June-Koo Lee, Ashton Berger, Galen F. Gao, Binyamin Zhitomirsky, Wen-Wei Liang, Meng Zhou, Sitapriya Moorthi, Alice H. Berger, Eric A. Collisson, Michael C. Zody, Li Ding, Andrew D. Cherniack, Gad Getz, Olivier Elemento, Christopher C. Benz, Josh Stuart, J. C. Zenklusen, Rameen Beroukhim, Jason C. Chang, Joshua D. Campbell, D. Neil Hayes, Lixing Yang, Peter W. Laird, John N. Weinstein, David J. Kwiatkowski, Ming S. Tsao, William D. Travis, Ekta Khurana, Benjamin P. Berman, Katherine A. Hoadley, Nicolas Robine, Matthew Meyerson, Ramaswamy Govindan, Marcin Imielinski

CELL REPORTS (2021)

Article Oncology

Functional Genomic Analysis of CDK4 and CDK6 Gene Dependency across Human Cancer Cell Lines

Zhouwei Zhang, Lior Golomb, Matthew Meyerson

Summary: This study provides functional genomic insight into the sensitivity of cancer cells to CDK4 or CDK6 inhibition, and identifies unique cancer cell populations that might be sensitive to CDK4-selective or CDK6-selective inhibitors.

CANCER RESEARCH (2022)

Article Microbiology

Long-read sequencing reveals complex patterns of wraparound transcription in polyomaviruses

Jason Nomburg, Wei Zou, Thomas C. Frost, Chandreyee Datta, Shobha Vasudevan, Gabriel J. Starrett, Michael J. Imperiale, Matthew Meyerson, James A. DeCaprio

Summary: The study compares the transcriptome of different polyomaviruses and identifies complex transcription patterns and novel transcripts that increase the coding capacity of the viruses. This research provides insights into the transcriptome architecture of polyomaviruses and their role in human diseases.

PLOS PATHOGENS (2022)

Article Genetics & Heredity

Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors

Netta Makinen, Meng Zhou, Zhouwei Zhang, Yosuke Kasai, Elizabeth Perez, Grace E. Kim, Chrissie Thirlwell, Eric Nakakura, Matthew Meyerson

Summary: This study reveals the major genomic diversity among multifocal ileal NETs, showing that synchronous primary tumors within each patient develop independently with different somatic variations. Additionally, tumors from the same patient can gain or lose different parental alleles, emphasizing the need to identify and remove all primary tumors to prevent metastasis and to optimize targeted treatments.

GENOME MEDICINE (2022)

Editorial Material Oncology

Fusobacterium and Colorectal Cancer: Important Association or Random Coincidence?

Blake E. Sanders, Guanxi Qiao, Jodi Hirschman, Matthew Meyerson

Summary: The role of the microbiome in human cancer is a subject of intense research and debate. The physical association of Fusobacterium with colorectal cancer has been extensively studied, offering potential for diagnosis and treatment, but controversies remain regarding the impact of Fusobacterium species on colorectal cancer proliferation and the immune microenvironment.

CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

Velcrin-induced selective cleavage of tRNALeu(TAA) by SLFN12 causes cancer cell death

Sooncheol Lee, Stephanie Hoyt, Xiaoyun Wu, Colin Garvie, Joseph McGaunn, Mrinal Shekhar, Marcus Totzl, Matthew G. Rees, Andrew D. Cherniack, Matthew Meyerson, Heidi Greulich

Summary: The study reveals that Velcrin compounds kill cancer cells by inducing complex formation between phosphodiesterase 3A (PDE3A) and Schlafen family member 12 (SLFN12). SLFN12 specifically digests tRNA(Leu)(TAA), and Velcrin treatment promotes the cleavage of tRNA(Leu)(TAA) by inducing PDE3A-SLFN12 complex formation. This leads to downregulation of tRNA(Leu)(TAA), ribosome pausing at Leu-TTA codons, and global inhibition of protein synthesis, defining a new mechanism of apoptosis initiation.

NATURE CHEMICAL BIOLOGY (2023)

暂无数据